International safety notice

Urgent Field Safety Notification / Increased Risk of Cardiovascular Death with Adaptive Servo-Ventilation (ASV) Therapy For Patients with Symptomatic Chronic Heart Failure with Reduced Ejection Fraction, ResMed Ltd

Germany / BfArM · DEU · May 13, 2015

Key facts

Title Urgent Field Safety Notification / Increased Risk of Cardiovascular Death with Adaptive Servo-Ventilation (ASV) Therapy For Patients with Symptomatic Chronic Heart Failure with Reduced Ejection Fraction, ResMed Ltd
Regulator Germany / BfArM
Country DEU
Brand Urgent Field Safety Notification / Increased Risk of Cardiovascular Death with Adaptive Servo-Ventilation (ASV) Therapy For Patients with Symptomatic Chronic Heart Failure with Reduced Ejection Fraction, ResMed Ltd
Manufacturer Urgent Field Safety Notification / Increased Risk of Cardiovascular Death with Adaptive Servo-Ventilation (ASV) Therapy For Patients with Symptomatic Chronic Heart Failure with Reduced Ejection Fraction, ResMed Ltd
Models 0488702, 33805408804, 77310405, 0805408804, 33426100349, 2770400
Date May 13, 2015
Regulator page bfarm.de

At a glance

  • No Recall
  • No Field safety notice

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About International device safety notices

Field safety notices, recalls and safety alerts published by about 30 national medical device regulators outside the United States, matched by Orca1 to FDA device data.

Source: National medical device regulators (as listed), compiled by Orca1

Browse all International device safety notices